Skip to main content
logo
Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.50685
+0.0289 (6.04%)
Aug 18, 2026, 12:44 PM EDT - Market open

Pasithea Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-----0.02
Revenue Growth
------
Gross Profit
------0
Operating Income
-19.79-16.69-14.25-15.98-12.59-4.51
Net Income
-21.29-20.43-13.9-15.96-13.94-2.17
Earnings Per Share
-1.11-2.91-12.69-13.01-11.04-4.18
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
45.6655.166.9216.3333.0952.97
Total Debt
---0.080.5-
Net Cash (Debt)
45.6655.166.9216.2532.5852.97
Net Cash Growth
532.72%696.78%-57.40%-50.13%-38.48%21638.85%
Net Cash Per Share
2.387.856.3213.2525.81101.81

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-17.78-15.21-13.92-13.43-13.69-3.17
Capital Expenditures
----0.03-0.11-0.02
Free Cash Flow
-17.78-15.21-13.92-13.46-13.8-3.2
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------14.69%
Operating Margin
------29925.73%
Pretax Margin
------14430.49%
Profit Margin
------14430.49%
FCF Margin
------21216.05%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----2572.20